Glaucoma Consultant  ·  Clinical Researcher  ·  Conference Speaker

Clinical precision.
Research depth.
Industry insight.

Dr. Sampson Abu is a board-certified medical optometrist and glaucoma researcher who consults for pharmaceutical and medtech organizations on glaucoma progression, OCT diagnostics, and ocular disease management. He is available for advisory boards, speaking engagements, and consulting projects.

16+Peer-Reviewed Publications
12+Conference Presentations
4+Years Postdoctoral Research
25+Articles Peer Reviewed
Dr. Sampson L. Abu, glaucoma consultant and medical optometrist
  • OD, Pennsylvania College of Optometry, Salus University
  • BSc/OD, University of Cape Coast, Ghana
  • Ocular Disease Residency, Omni Eye Services, Atlanta
  • Fellow, American Academy of Optometry (FAAO)
  • Diplomate, American Board of Optometry
  • NIH Postdoctoral Fellow, University of Alabama at Birmingham
  • Associate Optometrist, Thomas Eye Center, Athens, GA
  • Peer reviewer: IOVS, British Journal of Ophthalmology, Scientific Reports, and others

Researcher.
Clinician.
Consultant.

Dr. Sampson L. Abu is a board-certified medical optometrist based in Athens, Georgia, with a clinical focus on glaucoma, dry eye disease, neuro-ophthalmic conditions, and vascular ocular disease. He manages complex ocular disease at Thomas Eye Center and brings that patient care perspective directly to his consulting work.

His postdoctoral research at the University of Alabama at Birmingham was NIH-funded and focused on novel strategies for early detection of glaucoma progression, including individualized structure-function models, postprocessed visual field analysis, and real-world medication adherence in glaucoma patients. He trained under Dr. Lyne Racette, one of the leading researchers in glaucoma perimetry.

His work has appeared in Ophthalmology, Translational Vision Science and Technology, Scientific Reports, Journal of Glaucoma, PLOS ONE, and more than a dozen other peer-reviewed journals. He has presented original research at ARVO, the World Glaucoma Congress in Helsinki, the North American Perimetric Society, and multiple American Academy of Optometry annual meetings. He reviews manuscripts for Investigative Ophthalmology and Vision Science, the British Journal of Ophthalmology, and several other journals.

Dr. Abu was born in Ghana and completed his optometry training across three countries before his postdoctoral fellowship in the United States. For pharmaceutical companies thinking about diverse patient populations, health equity data, or sub-Saharan African markets, that background is directly relevant. His published work includes research on glaucoma medication adherence conducted in Ghana, one of very few studies of its kind from that region.

His research informs his clinical decisions, and his clinical practice keeps his research grounded. That feedback loop is what makes his consulting input different from what you get from a full-time academic or a retired clinician.

Clinical and research depth
in glaucoma and ocular disease

Clinical Areas

  • Glaucoma diagnosis, staging, and progression monitoring
  • OCT interpretation and structural retinal analysis
  • Visual field testing and progression analysis
  • Dry eye and ocular surface disease
  • Neuro-ophthalmic conditions
  • Diabetes-related ocular complications
  • Contact lens and anterior segment disease

Research Areas

  • Glaucoma progression detection and structure-function modeling
  • OCT and visual field data integration
  • Retinal nerve fiber layer (RNFL) analytics
  • Medication adherence in glaucoma
  • Diagnostic test validation and clinical endpoint design
  • Ocular surface inflammation and immunology
  • Optometric education and eyecare access in Africa

Selected Publications

Full publication list on Google Scholar

Active peer reviewer for Investigative Ophthalmology and Vision Science, the British Journal of Ophthalmology, Ophthalmic and Physiological Optics, Scientific Reports, and the Journal of Optometry. Over 25 manuscripts reviewed.

Research-grounded presentations
for clinical and industry audiences.

Dr. Abu is an experienced scientific presenter who has spoken at international glaucoma and optometry conferences across North America, Europe, and Africa. He is available for pharmaceutical industry symposia, medical education programs, conference keynotes, and clinical advisory panels. His presentations are research-grounded and he is comfortable adjusting the level of detail for audiences ranging from specialist researchers to clinical affairs and commercial teams.

Speaker Bio

Dr. Sampson L. Abu is a board-certified medical optometrist and NIH-funded glaucoma researcher based in Athens, Georgia. He completed a postdoctoral fellowship at the University of Alabama at Birmingham, where his research focused on early detection of glaucoma progression using structure-function modeling, OCT analytics, and visual field analysis. He is a Fellow of the American Academy of Optometry and a Diplomate of the American Board of Optometry, with more than 16 peer-reviewed publications and presentations at ARVO, the World Glaucoma Congress, and the American Academy of Optometry. He practices at Thomas Eye Center in Athens, Georgia.

This bio may be used in conference programs and event materials.
01

Glaucoma Progression Detection: Structure-Function Modeling and OCT Analytics

Attendees leave with a clear picture of where current detection methods fall short and what combining structural and functional data actually changes for clinical decision-making and trial design.

02

Evaluating Glaucoma Diagnostic Technology: A Clinical Research Perspective

Practical criteria for assessing new ophthalmic diagnostics. Useful for product and clinical affairs teams that need a clinician's view on what makes a tool viable in real practice.

03

Medication Adherence in Glaucoma: Research Findings and Clinical Implications

Published findings on adherence patterns, pandemic disruption, and racial disparities — and what they mean for how drugs are designed, packaged, and supported in the real world.

04

OCT and Visual Field Integration: What the Data Actually Tells Us

A frank look at what RNFL and visual field metrics reliably measure, where they disagree, and what that means for anyone using them as endpoints or marketing claims.

Book Dr. Abu for Your Event

Selected Conference Presentations

Evaluating Focal RNFL Thinning in Monitoring Glaucoma Progression
American Academy of OptometryNew Orleans, LA2023
Sensitivity of Postprocessed Visual Field Data to Identify Rapid Glaucoma Progression
American Academy of OptometryBoston, MA2021
Assessing the Intereye Relationship in Glaucomatous Visual Field Progression
AAO / World Congress of OptometryOrlando, FL2019
Predicting Glaucoma Progression in One Eye Based on the Fellow Eye
ARVO Annual MeetingVancouver, Canada2019
Predicting Conversion from Ocular Hypertension to Primary Open-Angle Glaucoma
World Glaucoma CongressHelsinki, Finland2017
Comparing Structural and Functional Measurements for Glaucoma Progression Detection
North American Perimetric SocietySkaneateles, NY2017

Honors & Recognition

2024
Rick Bay Excellence in Eyecare Education Scholarship
Pennsylvania College of Optometry
2023
N. Rex Ghormley Student Travel Fellowship
American Academy of Optometry Foundation
2021
Frank W. Weymouth Student Travel Fellowship
American Academy of Optometry Foundation
2021
ARVO Travel Award
Association for Research in Vision and Ophthalmology
2018
Roche Collaborative Research Award
ARVO, for glaucoma medication adherence research in Ghana
2018
David and Diane Goss Optometry History Fellowship
AAO Foundation, for research on optometric education in Africa
Invite Dr. Abu to Speak

Glaucoma consulting for
pharmaceutical and medtech teams.

Dr. Abu works with pharmaceutical and medical device organizations that need a clinical expert in glaucoma and ocular disease. His value is specific: he sees glaucoma patients in clinic, has published original research on glaucoma progression and diagnostic methods, and understands what the science actually looks like in practice. Companies working on glaucoma drugs, diagnostic devices, or patient adherence programs hire that combination.

Industry track record: Dr. Abu's research on glaucoma medication adherence was selected for the Roche Collaborative Research Award through ARVO, recognizing industry-relevant scientific contributions in ocular disease.

Glaucoma Diagnostic Evaluation

Clinical review of OCT devices, visual field software, and diagnostic analytics for product validation, regulatory support, and market positioning.

Glaucoma Progression Consulting

Clinical and research perspective on progression monitoring, structural and functional endpoints, and the practical limits of current diagnostic tools.

Clinical Trial Design Support

Input on study protocols, primary and secondary endpoints, patient selection criteria, and methodological considerations for glaucoma and ocular disease trials.

Advisory Board Participation

Ongoing participation as a clinical advisor or scientific reviewer for pharmaceutical and device programs in glaucoma and ocular disease.

Scientific Content Review

Clinical accuracy review of educational materials, manuscripts, promotional content, and monographs related to glaucoma and ophthalmic therapeutics.

Medication Adherence Consulting

Research-based perspective on glaucoma adherence patterns, patient behavior, and what published data suggests for drug formulation, packaging, and support programs.

Interested in working together?Dr. Abu takes on a limited number of consulting engagements. Reach out to discuss scope, availability, and fit.

Start a Conversation

Get in touch.

For speaking invitations, consulting inquiries, advisory board opportunities, or media requests, use the form or reach out directly by email. Dr. Abu reviews all inquiries personally and typically responds within 48 hours.

Athens, Georgia

Typically responds within 48 hours.